Pfizer Inc. Stock
Pfizer Inc. Stock
We can see a decrease in the price for Pfizer Inc.. Compared to yesterday it has lost -€0.550 (-1.660%).
With 26 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of €36.00 there is a slightly positive potential of 10.075% for Pfizer Inc. compared to the current price of €32.71.
Our community identified positive and negative aspects for Pfizer Inc. stock for the coming years. 9 users see the criterium "Worthwhile Investment for the next years" as a plus for the Pfizer Inc. stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.
Pros and Cons of Pfizer Inc. in the next few years
Pros
9
Could be worthwhile Investment >10% per year
7
Known brand
6
Market Leader or Top 3
Cons
3
Sustainability is little important
Performance of Pfizer Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | -1.660% | -1.342% | -0.335% | 14.904% | 8.116% | 9.571% | 13.020% |
| AbbVie Inc. | -1.250% | 0.000% | -0.459% | 10.081% | 11.406% | 12.061% | 78.822% |
| Eli Lilly Corp. | -1.150% | -0.486% | 12.868% | 28.883% | 35.461% | 146.454% | 183.385% |
| Alexion Pharmaceutical Inc. | 0.540% | 1.506% | 4.401% | 42.790% | 19.115% | 41.674% | 38.455% |
Comments
Other discussions about Pfizer Inc. Stock
Trading Pfizer Inc.
Trading Pfizer Inc.
News
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Pfizer Inc. (NYSE: PFE) and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive
Pfizer Invites Public to View and Listen to Webcast of Pfizer July 28 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Wednesday, July 28, 2021. The
Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200